Medtronic Evolut Transcatheter Aortic Valve Replacement in Low Risk Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- John K. Forrest, MD
Yale New Haven Hospital
Principal Investigator - Michael Reardon, MD
The Methodist Hospital Research Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
87 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Saint Vincent'S Hospital Sydney
Darlinghurst, New South Wales, Australia
- Royal North Shore Hospital
St Leonards, New South Wales, Australia
- Monash Health
Clayton, Victoria, Australia
- the Alfred Hospital
Melbourne, Victoria, Australia
- Fiona Stanley Hospital (fsh)
Murdoch, Western Australia, Australia
- London Health Sciences Centre
London, Ontario, Canada
- Toronto General Health Hospital
Toronto, Ontario, Canada
- Glen Royal Victoria (mcgill)
Montreal, Quebec, Canada
- Iucpq
Québec, Quebec, Canada
- Montreal Heart
Montreal, Canada
- Sunnybrook Health Sciences Centre
Toronto, Canada
- Centre Hospitalier Régional Universitaire de Lille
Lille, France
- L'Hôpital Privé Jacques Cartier Massy
Massy, France
- Clinique Pasteur
Toulouse, France
- Kokura Memorial Hospital
Kitakyushu, Fokuoka, Japan
- Sapporo Higashi Tokushukai Hospital
Sapporo, Hokkaido, Japan
- Teikyo University Hospital
Tokyo, Itabashi-Ku, Japan
- Shonan Kamakura General Hospital
Kamakura, Kanagawa, Japan
- Sendai Kousei Hospital
Sendai, Miyagi, Japan
- National Cerebral and Cardiovasclular Center
Suita, Osaka, Japan
- the University of Osaka Hospital
Suita, Osaka, Japan
- Sakakibara Heart Institute
Fuchū, Tokyo, Japan
- Catharina Ziekenhuis
Eindhoven, Netherlands
- St. Antonius Hospital Nieuwegein
Nieuwegein, Netherlands
- Erasmus Medisch Centrum
Rotterdam, Netherlands
- Waikato Hospital
Hamilton, New Zealand
- Abrazo Arizona Heart Hospital
Phoenix, Arizona, United States
- Scripps Memorial Hospital la Jolla
La Jolla, California, United States
- University of Southern California University Hospital
Los Angeles, California, United States
- El Camino Hospital
Mountain View, California, United States
- Mercy General Hospital
Sacramento, California, United States
- Los Robles Hospital & Medical Center
Thousand Oaks, California, United States
- University of Colorado Hospital
Aurora, Colorado, United States
- Yale New Haven Hospital
New Haven, Connecticut, United States
- Morton Plant Hospital
Clearwater, Florida, United States
- Delray Medical Center
Delray Beach, Florida, United States
- Healthpark Medical Center
Fort Myers, Florida, United States
- University of Miami Hospital
Miami, Florida, United States
- Tallahassee Research Institute, Inc.
Tallahassee, Florida, United States
- Piedmont Atlanta Hospital
Atlanta, Georgia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2016
- Primary completion
- 30 Apr 2021
- Completion
- 30 Jun 2029
- Last update posted
- 7 May 2026
- Registered enrollment
- 2,223
- Registry id
- NCT02701283
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.